184 Grants (Page 2 of 8)
2017
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5U54DK106846-03), $948,547USD, 08/01/2015 -- 07/31/2020
 
Mechanisms of Synergistic Regulation of Stem/Progenitors
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL056416-20), $390,000USD, 04/01/1996 -- 04/30/2018
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 3T32DK007519-31S1), $888USD, 07/01/1985 -- 06/30/2021
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5T32DK007519-32), $381,296USD, 07/01/1985 -- 06/30/2021
2016
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-17), $523,280USD, 07/01/1999 -- 11/30/2019
 
DEK Regulation of Hematopoietic Stem Cell Renewal, Fate, and Hematopoiesis
Broxmeyer, Hal E and Markovitz, David M
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 1R01DK109188-01), $512,978USD, 07/01/2016 -- 05/31/2020
 
Enhancing Engraftment of Cord Blood by CD26 Inhibition
Broxmeyer, Hal E and Farag, Sherif S
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 4R01HL112669-05), $720,299USD, 03/01/2012 -- 02/28/2017
 
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5U54DK106846-02), $977,986USD, 08/01/2015 -- 07/31/2020
 
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 3U54DK106846-02S1), $67,054USD, 08/01/2015 -- 07/31/2020
 
Mechanisms of Synergistic Regulation of Stem/Progenitors
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL056416-19), $390,000USD, 04/01/1996 -- 04/30/2018
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 2T32DK007519-31), $93,114USD, 07/01/1985 -- 06/30/2021
2015
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2T32HL007910-16), $494,630USD, 07/01/1999 -- 11/30/2019
 
Enhancing Engraftment of Cord Blood by CD26 Inhibition
Broxmeyer, Hal E and Farag, Sherif S
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL112669-04), $720,286USD, 03/01/2012 -- 02/28/2017
 
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 1U54DK106846-01), $995,319USD, 08/01/2015 -- 07/31/2020
 
Mechanisms of Synergistic Regulation of Stem/Progenitors
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL056416-18), $384,150USD, 04/01/1996 -- 04/30/2018
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5T32DK007519-30), $196,820USD, 07/01/1985 -- 06/30/2016
2014
Cytokine Enhancement of Myeloid Progenitor Cell Survival
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL067384-12), $366,417USD, 06/15/2001 -- 06/30/2015
 
Enhancing Engraftment of Cord Blood by CD26 Inhibition
Broxmeyer, Hal E and Farag, Sherif S
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL112669-03), $727,047USD, 03/01/2012 -- 02/28/2017
 
Mechanisms of Synergistic Regulation of Stem/Progenitors
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R01HL056416-17), $390,000USD, 04/01/1996 -- 04/30/2018
 
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5P30DK090948-05), $717,351USD, 09/30/2010 -- 06/30/2015
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5T32DK007519-29), $499,659USD, 07/01/1985 -- 06/30/2016
2013
Basic Science Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-15), $170,675USD, 07/01/1999 -- 11/30/2014
 
Cytokine Enhancement of Myeloid Progenitor Cell Survival
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL067384-11), $356,256USD, 06/15/2001 -- 06/30/2015
 
Enhancing Engraftment of Cord Blood by CD26 Inhibition
Broxmeyer, Hal E and Farag, Sherif S
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL112669-02), $716,107USD, 03/01/2012 -- 02/28/2017
 
Mechanisms of Synergistic Regulation of Stem/Progenitors
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL056416-16), $362,855USD, 04/01/1996 -- 06/30/2014